Karen E. Effinger

Learn More
Multi-modality therapy has resulted in improved survival for childhood malignancies. The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers provide practitioners with exposure- and risk-based recommendations for the surveillance and management of asymptomatic survivors who are at least 2(More)
Background The effect of temporal changes in cancer therapy on health status among childhood cancer survivors has not been evaluated. Objective To compare proportions of self-reported adverse health status outcomes among childhood cancer survivors across 3 decades. Design Cross-sectional. (ClinicalTrials.gov: NCT01120353). Setting 27 North American(More)
BACKGROUND Prior research on trends in neuroblastoma incidence has conflicted. We aimed to compare how ganglioneuroblastoma and neuroblastoma incidence have changed. PROCEDURE Using the Surveillance Epidemiology and End Results (SEER) 9 population-based registry, we identified 2081 malignant peripheral neuroblastic tumors in patients 0 to 14 years from(More)
  • 1